EmGenisys has secured a central IRB approval and launched a multi-site embryo data study in partnership with the University of Pennsylvania and Women's Fertility and Specialty Center in Clovis, California. The company submitted two research abstracts for presentation at the American Association of Bioanalysts conference in Las Vegas in May — and a team member […]

Only subscribers get to read this.

Hit SUBSCRIBE for freemium or paid content access.